Abstract
Nurse PrescribingVol. 15, No. 11 NewsNew drug nivolumab to be allowed for use in head and neck cancerAysha Mendes, Sarah Jane PalmerAysha MendesSearch for more papers by this author, Sarah Jane PalmerSearch for more papers by this authorAysha Mendes; Sarah Jane PalmerPublished Online:9 Nov 2017https://doi.org/10.12968/npre.2017.15.11.526AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article References National Institute for Health and Care Excellence. Guidance on Cancer Services: Improving Outcomes in Head and Neck Cancers. 2004. https://www.nice.org.uk/guidance/csg6/resources/improving-outcomes-in-head-and-neck-cancers-update-pdf-773377597 (accessed 20 October 2017) Google ScholarNHS. Head and neck cancer. 2016. https://www.nhs.uk/conditions/cancer-of-the-head-and-neck/Pages/Definition.aspx (accessed 20 October 2017) Google ScholarNational Institute for Health and Care Excellence. Hundreds of patients to have access to head and neck cancer drug after new deal, says NICE. 2017a. https://www.nice.org.uk/news/article/hundreds-of-patients-to-have-access-to-head-and-neck-cancer-drug-after-new-deal-says-nice (accessed 20 October 2017) Google ScholarNational Institute for Health and Care Excellence. Treatment of upper aerodigestive tract cancer. 2017b. https://pathways.nice.org.uk/pathways/upper-aerodigestive-tract-cancer#path=view%3A/pathways/upper-aerodigestive-tract-cancer/treatment-of-upper-aerodigestive-tract-cancer.xml&content=view-node%3Anodes-squamous-cell-cancer (accessed 20 October 2017) Google Scholar FiguresReferencesRelatedDetails 2 November 2017Volume 15Issue 11ISSN (print): 1479-9189ISSN (online): 2052-2924 Metrics History Published online 9 November 2017 Published in print 2 November 2017 Information© MA Healthcare LimitedPDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
